Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Evaluation of RPH-104 Administered at Different Doses to Patients With Acute Gout Attack
Clinical trial NCT04067492 · TERMINATED
Trial details
- NCT number
- NCT04067492
- Sponsor
- R-Pharm
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-26
- Primary completion
- 2020-03-16
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.